Dr. Mathew Wayne Whitest ‘87

Dr. Mathew Wayne Whitest ‘87Dr. Whitest and his team at Wayne Pharmaceuticals, recently completed several months of negotiations that resulted in them acquiring a licensing agreement for a Vaccine in development at the University of Massachusetts Medical School that will prevent the contraction of HIV. This vaccine which is showing great promise is slated to begin clinical trials in early 2016, and will continue to be developed at the medical school. However, Dr. Whitest and Wayne Pharmaceuticals own the exclusive license agreement for the vaccine and will manage the vaccine at their new location in Cordele Georgia. They are acquiring a school, A.S. Clark, in Cordele in partnership with their non-profit partner the M.D. Whitest Medical Institute and converting it into a Biomedical center that will house the management of their Vaccine programs inclusive of the HIV Vaccine technology program. This is a historic event as it represents the engagement of the African American community in the search for a cure for HIV infection in a major Research capacity, as Dr. Whitest is of African American descent.